ABUJA, NIGERIA — The National Agency for Food and Drug Administration and Control has issued an urgent NAFDAC defective medicines warning cautioning healthcare providers and consumers against purchasing or using four pharmaceutical products recalled due to quality defects. The public health alert follows a regulatory recall initiated by the Drug Regulatory Authority of Pakistan over substandard and adulterated formulations.
The affected medications include Nitras tablets (glyceryl trinitrate), classified as substandard, along with three adulterated products: Kadin 2 tablets (tizanidine hydrochloride), Acefyl cough syrup (acefylline piperazine), and Loratadine 24 tablets.
Risks Outlined in the NAFDAC Defective Medicines Warning
According to regulatory officers, compromised pharmaceutical products present significant medical risks, including severe therapeutic failure, unforeseen adverse drug reactions, and toxicity. The greatest health hazards target patients undergoing treatment for cardiac disorders, muscle spasms, respiratory ailments, and allergic reactions.
Product Name
Active Ingredient
Classification
Target Health Condition
Nitras Tablets
Glyceryl Trinitrate
Substandard
Cardiac conditions / Angina
Kadin 2 Tablets
Tizanidine Hydrochloride
Adulterated
Muscle spasms
Acefyl Cough Syrup
Acefylline Piperazine
Adulterated
Cough / Respiratory issues
Loratadine 24 Tablets
Loratadine
Adulterated
Allergies
Reporting Protocols and Consumer Guidance
NAFDAC urges all community pharmacies, hospitals, and drug distributors to procure pharmaceutical supplies exclusively from licensed importers and authorized vendors. Anyone possessing or identifying these recalled batches should immediately notify the agency via its toll-free line (0800-162-3322) or by email at nafdac@nafdac.gov.ng.
Why It Matters: Cross-border regulatory alerts serve as a vital defense line to prevent contaminated and defective imported pharmaceuticals from entering local supply chains and endangering patients.
NAFDAC's Plan to Review Sanctions on Exporters of… The National Agency for Food and Drug Administration and Control (NAFDAC) has announced its intention to review the sanctions imposed on exporters of substandard products [1]. This decision comes in response to the increasing rejection of…
NAFDAC Issues Strong Warning Against Consuming… National Agency for Food and Drugs Administration and Control (NAFDAC) Cautions Nigerians on the Dangers of Chemically Ripened Fruits In a stern warning to the public, the National Agency for Food and Drugs Administration and…
NAFDAC Issues Warning: Avoid Recalled High-Caffeine… The National Agency for Food and Drugs Administration and Control (NAFDAC) has issued a public warning, urging consumers to steer clear of G Fuel brand Energy Drinks due to their significantly high caffeine content. This…
Blood Pressure Medication Side Effects and What to Do Most people never tell anyone about their blood pressure medication side effects. They notice their ankles have swollen, or that a dry cough has not gone away since February, and they draw the obvious conclusion:…
